肺表面活性剂生物发生阻断介导的聚乙烯瓜尼丁消毒剂诱导的肺纤维化
Xin Li1, Jianzhong Zhang1, Mingyue Wang2
1Clinical Medical Research Center for Women and Children Diseases, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan 250001, China; Department of Environmental and Occupational Health, School of Public Health, Qingdao University, Qingdao 266071, China; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, China.
吸入聚乙烯瓜尼丁 (PHMG) 消毒剂会通过破坏自和阻断肺细胞表面活性剂的产生引起肺纤维化. 甲胺干预表明,自功能障碍是这种肺部疾病的关键机制.
科学领域:
- 毒理学 毒理学 毒理学
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
背景情况:
- 消毒剂的使用,特别是气溶聚乙烯瓜尼丁 (PHMG),与呼吸系统问题和肺纤维化有关.
- 在PHMG诱导的肺纤维化背后的精确机制仍然在很大程度上是未知的.
研究的目的:
- 研究PHMG吸入对肺纤维化的时间效应.
- 阐明PHMG诱导的肺损伤的潜在细胞和分子机制.
主要方法:
- 单细胞RNA测序 (scRNA-seq) 用于分析细胞变化.
- 在体外和体内研究,以评估PHMG对膜II型上皮细胞 (AT2) 的影响.
- 使用甲胺进行干预研究,以探索治疗点.
主要成果:
- 在诱导性肺纤维化期间,PHMG暴露随着时间的推移改变了上皮细胞数量.
- PHMG破坏了自流,导致细胞内积累和AT2细胞中的肺表面活性剂生物生成受损.
- 甲胺干预证实了自功能障碍在阻断表面活性剂生物发生和调解PHMG诱导的纤维化中的作用.
结论:
- 吸入PHMG会通过干扰自和阻断AT2细胞表面活性生物生成的机制诱导肺纤维化.
- 自功能障碍是PHMG相关的肺纤维化中的关键调解者.
- 了解这些毒理途径为PHMG诱导的肺部疾病提供了潜在的治疗点.
相关概念视频
Breathing
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Gene Regulation in Microbial Communities: Quorum Sensing
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...


